Market Scenario
The global biopreservation market size is expected to grow during the forecast period (2018–2023) at a CAGR ~11.2%.
Biopreservation is a use of natural flora and its antibacterial products to preserve biological material. Biopreservation is playing an important role in healthcare and food industry to preserve the biological material or food product for a long time. The increasing expenditure on healthcare, growing demand for stem cell preservation and awareness about its use with regards to treatment of diseases are expected to drive the growth of the market. Moreover, increasing awareness about personalized medicines and its applications are contributing to the growth of the market. According to the US Food and Drug Administration (FDA), The department has approved 16 personalized medicines in the year 2017, which accounts for 20% of total drug approvals.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6407
The rising high price of biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.
Segmentation
The global biopreservation market has been segmented on the basis of product, biospecimen, and application.
On the basis of product, the market has been classified as media and equipment. The media subsegment has been further divided into nutrient media, sera, and growth factors and supplements. The equipment segment has been further divided into temperature control systems, accessories, alarms & monitoring systems, incubators, centrifuges, and other equipment. The temperature control systems segment has been further classified as freezers, cryogenic storage systems, thawing equipment, and refrigerators. The biospecimen segment has been divided into human tissue samples, organs, stem cells, and other biospecimens.
The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biopreservation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European biopreservation market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The biopreservation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biopreservation market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas are likely to dominate the global biopreservation market owing to the adoption of advanced technology, increasing spending on healthcare R&D, the presence of a well-established healthcare system, and increasing in-house sample storage in hospitals and research institutes. Moreover, presence and recent merger and acquisition activities by market players in the region are contributing to the growth of the market. For instance, in 2017, Cesca Therapeutics Inc. has acquired Sacramento’s SynGen Inc. for USD 1 million with this acquisition company has managed to add cell separation and cord blood processing products in their portfolio.
The European market is expected to be the second-largest biopreservation market. The market growth in this region can be attributed to the increasing number of births and with-it continuous increase in demand for umbilical cord preservation. According to the European Commission, in the year 2016 more than 5.1 million babies were born in Europe. Moreover, a growing number of sperm and egg banks is contributing to the growth of the market in this region.
Asia-Pacific is expected to be the fastest-growing biopreservation market during the forecast period owing to the increasing population in the region, increasing awareness about stem cell preservation and continuous development in the healthcare sector due to government funding.
The market in the Middle East & Africa is expected to account for the smallest share of the global biopreservation market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global biopreservation market are Thermo Fisher Scientific, Inc, VWR International, LLC., CUSTOM BIOGENIC SYSTEMS., BioLifeSolutions Inc., BioCision., Sigma-Aldrich Co., QIAGEN, Lifeline Scientific, Cesca Therapeutics Inc., Core Dynamics, Ltd., Princeton CryoTech, Biomatrica, Inc., Panasonic Biomedical, Inc., Chart Industries, and ATLANTA BIOLOGICALS
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/biopreservation-market-6407
Market SynopsisAs per the assessment by Market Research Future (MRFR), the global calf milk replacers market is anticipated to reach a significant value, at a CAGR of 6.7% during the forecast period from 2017-2023.The growing dairy industry is anticipated to boost the calf milk replacers market 2020 due to the rising milk consumption for commercial use.
The escalating demand for quality milk products is predicted to increase the need for calf replacers which is expected to underpin the market expansion.
Calf milk replacers are likely to gain traction for it is an efficient alternative to cow's milk that can control the spread of disease to calves, which can strengthen the market in the review period.
Furthermore, the product's long shelf is expected to increase its demand and support market expansion during the projection periodAccess Report Details @ https://www.marketresearchfuture.com/reports/calf-milk-replacers-market-5191On the flip side, the rising concerns about animal welfare are projected to obstruct the market from expansion during the review period.
However, the adoption of precision techniques such as phase feeding processes is anticipated to aid calf milk replacers' demand, which can boost the market growth.Market SegmentationThe segmental analysis of the global calf replacers market size is done by type, form, and source.The type-based segments of the global calf replacers market size are medicated milk replacer and non-medicated milk replacer.
Between the two segments, the powdered segment is expected to acquire major market share during the forecast period.The source-based segments of the global calf replacers market size are dairy based and non-dairy based.
High disease prevalence across the globe coupled with ongoing research & development is expected to stimulate market growththe global Dystrophin Market was valued at 0.60 billion in 2018 and is expected to reach USD 13.02 billion by year 2026, at a CAGR of 47% percent.
The growth of the dystrophin market is more in countries such as U.S, Austria, Czech Republic, Denmark, Germany, Hungary, Israel, Italy, Norway, Portugal, Slovakia, South Korea, and the United Kingdom; where key muscular dystrophy drugs are available in the market.The market is characterized by the entry of a large number of players that includes emerging companies, as well as healthcare giants.
The primary factor, for the focus of market players, is the unaddressed demand for treatment of muscular dystrophy diseases for a long time.
There are over 35 companies engaged in clinical trials for the launch of novel therapeutics for the treatment of DMD.
However, owing to stringent regulation across the globe for drug approval, very few drug candidates have received approval by medicine regulatory bodies such as the US Food and Drug Administration (FDA), and European Commission.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1063 The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers.
The growth of the automotive industry since the last century has been rapid owing to the high technological advancements and developments from original equipment manufacturers (OEMs), tier 1 manufacturers, and tier 2 manufacturers.
However, the increasing number of vehicles on road also creates immense opportunity for vision and navigation system providers to integrate advanced safety driver-assistance systems (ADAS) features in the vehicle to increase road safety and provide secure movement of goods via commercial vehicles.
Owing to the rapid integration of ADAS features in a vehicle, the automotive industry is on the crest of technological advancement, which is expected to further increase in the coming years, thereby providing improved and enhanced safety features in Level 3, 4, and 5 vehicles.
The progressive evolution of automotive industry is attributed to the increasing focus of manufacturers toward the road safety, government regulations, and changing consumer preferences, which has led to the deployment of vehicles from Level 1 to Level 3.
Consequently, the advancement and improvement in on-road vehicles performance has created a surge in the demand for vehicles, thereby raising the need for safer and advanced features in it.The deployment of ADAS features in a vehicle makes the road safe for drivers as well as pedestrians.
The increasing number of road accidents has compelled the government bodies and federal authorities such as “National Highway Traffic Safety Administration” (NHTSA), “Ministry of Land, Infrastructure, Transport and Tourism” (MLIT), and “European Commission” (EC) to work toward the deployment of autonomous vehicle by passing stringent regulations and laws for automakers.
Flexible packaging is one of the fastest growing segments of the packaging industry and it integrates the best qualities of plastic, film, paper and aluminum foil to offer an extensive range of protective properties.
It essentially takes the shape of a bag, pouch, liner, or overwrap, or any part of a package whose shape can be readily changed.
According to a recent study report published by the Market Research Future, The global market of Confectionery Packaging is booming and expected to gain prominence over the forecast period.
Rise in demand for packaged foods & beverages including ready-to-eat meals, frozen meals, and snack foods.
Advanced technology in packaging has allowed companies for innovation in products instead of sticking to traditional methods of packaging.
Due to this, many companies are investing in R and are coming up with advanced flexible packaging products with barrier resistance properties that offer resistance against heat and moisture and eliminates oxidation of foods.
Global Immunofluorescence Assay Market Research Report, by Technique (Primary, Secondary), by Product Type (Antibodies, Kits), by Application (Clinical research), End-User (Clinical Diagnostics, Hospitals & Research Institutes) - Global Forecast Till 2027Market HighlightsThe global Immunofluorescence assays market is expected to reach an approximate CAGR of 5.8% during the forecast period.The growing prevalence of chronic and infectious diseases, increase in research and development activities, growing government investments for R activities, increased need for rapid and sensitive diagnostics, and adoption of technologically advanced systems are the key factors for the market to grow.
However, factors such as, expensive diagnostic kits, chances of cross contaminations, shortage of skilled labor and weak detection signals are expected to restrict the market growth during the forecast period.SegmentationThe global immunofluorescence assay market is segmented on the basis of technique, product type, application and end user.
On the basis of product type, the market is categorized into antibodies, kits and reagents, instruments, labelling dyes and species type.
According to the Partnership to Fight Chronic Disease (PFCD) in 2016, 190 million people in America are affected by at least one chronic disease.
In recent years, biotechnology sector in European Union, is the most innovative industry with 80 thousand patents in 2014.
Furthermore, according to the European Commission’s Directorate General for Enterprise and Industry, the European Union invested $7.32 billion in the Biotechnology sector.Asia Pacific is expected to witness fastest growth for the global Immunofluorescence assays market owing to large patient population, rapidly growing economies and increase in research and development expenditure.
